Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT04377555
Brief Title: Prospective Study to Assess Disease Activity and Biomarkers in Minority Participants With Relapsing Multiple Sclerosis (RMS) After Initiation and During Treatment With Ocrelizumab.

First Submitted : May 1, 2020
First Submitted that Met QC Criteria : May 5, 2020
First Posted : May 6, 2020

Last Update Submitted that Met QC Criteria : January 15, 2021
Last Update Posted : January 20, 2021